Chester County News and Community Website
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced its first-quarter 2025 financial results and shared updates on its strategy to evolve into a revenue-generating company while advancing its …
Windtree Therapeutics Reports Q1 2025 Financial Results and Strategic Milestones Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has released its financial results for the first quarter of 2025, along with key updates from its clinical development programs for QTORIN™ …
Palvella Therapeutics Reports Q1 2025 Financials and Clinical Progress Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has reported its first-quarter financial results and provided updates on its investigational antiviral programs, underscoring advancements toward regulatory approval and potential breakthroughs …
Traws Pharma Highlights Q1 2025 Financial Progress and Antiviral Developments Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced its financial results for the first quarter of 2025, showcasing modest revenue growth, improved gross margins, and expanding international …
STRATA Skin Sciences Reports Q1 2025 Financial and Operational Progress Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced substantial financial gains for the first quarter ending March 31, 2025, with revenue reaching $2.81 million. This marks a 121% increase year-over-year …
NEXGEL Reports 121% Revenue Growth in Q1 2025, Highlights Strong Momentum Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced significant progress in the first quarter of 2025, reporting $3.4 million in revenue from YCANTH. This figure reflects a …
Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) has shared its financial results for the first quarter of 2025, along with updates on its ongoing clinical programs and operational advancements. …
Passage Bio Reports Q1 2025 Financial Results and Highlights Progress in Gene Therapy Development Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for the first quarter ended March 31, 2025, alongside significant regulatory and clinical milestones that …
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has reported its financial results for the first quarter ended March 31, 2025, alongside major updates on its pivotal clinical trials and …
Mineralys Therapeutics Announces Q1 2025 Financial Results and Achievements Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) reported its first-quarter 2025 financial results, accompanied by updates on its pipeline progress and corporate milestones. The company continues to prioritize …
ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements Read More